ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 128 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,190 | -27.2% | 3,255 | +3.3% | 0.00% | – |
| Q2 2023 | $4,382 | -85.3% | 3,152 | -83.2% | 0.00% | – |
| Q1 2023 | $29,795 | -8.8% | 18,739 | +257.3% | 0.00% | – |
| Q4 2022 | $32,676 | -9.2% | 5,245 | -1.8% | 0.00% | – |
| Q3 2022 | $36,000 | -12.2% | 5,341 | -18.0% | 0.00% | – |
| Q2 2022 | $41,000 | -18.0% | 6,515 | -40.0% | 0.00% | – |
| Q1 2022 | $50,000 | -32.4% | 10,853 | -26.5% | 0.00% | – |
| Q4 2021 | $74,000 | +138.7% | 14,760 | +461.0% | 0.00% | – |
| Q3 2021 | $31,000 | -94.6% | 2,631 | -90.3% | 0.00% | – |
| Q2 2021 | $572,000 | +97.2% | 26,990 | +160.9% | 0.00% | – |
| Q1 2021 | $290,000 | -81.4% | 10,346 | -82.8% | 0.00% | – |
| Q4 2020 | $1,559,000 | -34.1% | 59,990 | -5.8% | 0.00% | -100.0% |
| Q3 2020 | $2,367,000 | -38.7% | 63,683 | -15.4% | 0.00% | 0.0% |
| Q2 2020 | $3,863,000 | +407.0% | 75,276 | +211.1% | 0.00% | – |
| Q1 2020 | $762,000 | -44.0% | 24,200 | +6.1% | 0.00% | – |
| Q4 2019 | $1,360,000 | +100.0% | 22,810 | +23.0% | 0.00% | – |
| Q3 2019 | $680,000 | -52.2% | 18,538 | -39.4% | 0.00% | – |
| Q2 2019 | $1,423,000 | +63.9% | 30,580 | +41.6% | 0.00% | – |
| Q1 2019 | $868,000 | +18.4% | 21,593 | +35.4% | 0.00% | – |
| Q4 2018 | $733,000 | +31.6% | 15,948 | +27.0% | 0.00% | – |
| Q3 2018 | $557,000 | -96.8% | 12,553 | -97.2% | 0.00% | -100.0% |
| Q2 2018 | $17,642,000 | +14.9% | 450,158 | +95.1% | 0.01% | 0.0% |
| Q1 2018 | $15,355,000 | +2212.5% | 230,791 | +2186.0% | 0.01% | – |
| Q4 2017 | $664,000 | -8.8% | 10,096 | -30.5% | 0.00% | – |
| Q3 2017 | $728,000 | +35.6% | 14,519 | +25.1% | 0.00% | – |
| Q2 2017 | $537,000 | +31.0% | 11,602 | 0.0% | 0.00% | – |
| Q1 2017 | $410,000 | +294.2% | 11,602 | +39.4% | 0.00% | – |
| Q4 2016 | $104,000 | +76.3% | 8,320 | +96.1% | 0.00% | – |
| Q3 2016 | $59,000 | -72.7% | 4,243 | -80.6% | 0.00% | – |
| Q2 2016 | $216,000 | +132.3% | 21,860 | +297.0% | 0.00% | – |
| Q1 2016 | $93,000 | -33.6% | 5,506 | -12.5% | 0.00% | – |
| Q4 2015 | $140,000 | -32.0% | 6,291 | -28.1% | 0.00% | – |
| Q3 2015 | $206,000 | -91.7% | 8,754 | -71.2% | 0.00% | -100.0% |
| Q2 2015 | $2,487,000 | -7.0% | 30,419 | +5.2% | 0.00% | 0.0% |
| Q1 2015 | $2,674,000 | +3242.5% | 28,906 | +1362.9% | 0.00% | – |
| Q4 2014 | $80,000 | +95.1% | 1,976 | +16.2% | 0.00% | – |
| Q3 2014 | $41,000 | +17.1% | 1,701 | -22.5% | 0.00% | – |
| Q2 2014 | $35,000 | +52.2% | 2,194 | +43.0% | 0.00% | – |
| Q1 2014 | $23,000 | +53.3% | 1,534 | +47.6% | 0.00% | – |
| Q4 2013 | $15,000 | -42.3% | 1,039 | -24.5% | 0.00% | – |
| Q3 2013 | $26,000 | – | 1,377 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,679,835 | $69,675,000 | 19.39% |
| Endurant Capital Management LP | 207,293 | $5,390,000 | 1.94% |
| Bellevue Group AG | 5,138,451 | $133,599,000 | 1.53% |
| Rhenman & Partners Asset Management AB | 592,225 | $15,398,000 | 1.26% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,562,869 | $40,635,000 | 0.93% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 31,434 | $817,000 | 0.62% |
| WASATCH ADVISORS LP | 3,998,010 | $103,949,000 | 0.51% |
| HAMILTON LANE ADVISORS LLC | 46,181 | $1,201,000 | 0.45% |
| Boxer Capital, LLC | 500,000 | $13,000,000 | 0.42% |
| DCF Advisers, LLC | 38,500 | $1,001,000 | 0.41% |